Medisus Pharma

Rybelsus 7 mg (semaglutide) is an oral prescription medication used to improve blood sugar control in adults with type 2 diabetes. It functions as a GLP-1 receptor agonist, increasing insulin release, reducing liver sugar production, and slowing gastric emptying. It is taken once daily on an empty stomach.

Rybelsus 14 mg (semaglutide) is an oral prescription medication used to improve blood sugar control in adults with type 2 diabetes, typically as a higher-dose maintenance treatment after increasing from 7 mg. It acts as a GLP-1 receptor agonist to increase insulin release, reduce glucagon, and slow digestion, often resulting in weight loss.

Rybelsus 3 mg tablets contain semaglutide and are used as a daily oral medication to improve glycemic control in adults with type 2 diabetes, typically used for the first 30 days to initiate treatment. It works by increasing insulin release, reducing glucagon secretion, and slowing gastric emptying to manage blood sugar levels.